Bienville Capital Management, LLC Merck & Co., Inc. Transaction History

Bienville Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $197,220 - $223,550	-2,695 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $189,781 - $215,950	2,695 New	2,695 $210,000
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $294,090 - $341,816	-5,771 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $60,601 - $72,365	-1,174 Reduced 16.9%	5,771 $328,000
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $407,463 - $438,437	6,945	6,945 $447,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Bienville Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bienville Capital Management, LLC with notifications on news.